VAERS reports by lot

GSK Varicella/Shingles lot HE2P5: VAERS reports

25 VAERS reports list lot HE2P5 as a GSK Varicella/Shingles vaccine, received between 2019-11-30 and 2020-11-06. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
25
Reports
8%
Marked serious
0
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)1420%
Injection-site / Local reaction1420%
Musculoskeletal1014%
Gastrointestinal811%
Cardiac / Cardiovascular710%
Neurological68%
Dermatological (non-injection-site)57%
Allergic / Anaphylactic46%
Psychiatric / Neuropsychiatric23%
Respiratory11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Ohio6
Pennsylvania5
New York2
Michigan2
Georgia1
New Jersey1
California1
Massachusetts1
Maryland1
Virginia1
Minnesota1
North Carolina1

Reports by month received

2019-111
2019-124
2020-015
2020-026
2020-041
2020-051
2020-072
2020-081
2020-091
2020-101
2020-112

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.